Company attributes
CEO
Pitchbook URL
Legal Name
Stoke Therapeutics Inc.
Legal classification
Date Incorporated
2014
Number of Employees (Ranges)
51 – 2000
Email Address
bd@stoketherapeutics.com0
ir@stoketherapeutics.com0
info@stoketherapeutics.com0
clinicaltrials@stoketherapeutics.com0
Phone Number
+17814308200
Number of Employees
1020
Full Address
45 Wiggins Avenue Bedford, MA 01730 United States0
139 Main Street, 4th Floor Cambridge, MA 021420
CIK Number
Place of Incorporation
Investors
IRS Number
471,144,5820
Founded Date
2017
0Total Funding Amount (USD)
235,100,000
Latest Funding Round Date
November 2020
Stock Symbol
STOK0
Exchange
Board of Directors
Also Known As
ASOthera Pharmaceuticals, Inc.
Latest Funding Type
NAICS Code
325,4120
Patents Assigned (Count)
2
COO
Country
Other attributes
Company Operating Status
Active
Previous Name
ASOthera Pharmaceuticals, Inc.0
SIC Code
2,8340
Ticker Symbol
STOK0
Stoke Therapeutics is a Massachusetts-based biotechnology that develops therapies that target RNA splicing to increase gene expression for the treatment of severe genetic diseases. The Stoke technology platform, Targeted Augmentation of Nuclear Gene Output, or #TANGO, allows the company to deliver disease-modifying therapies in a precise, durable and controlled manner.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
